Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Peixuan Guo
University of Kentucky, Department: Surgery
Should you be removed from our database? Contact us at [email protected]. Read more below.
Biomotor and Nucleic Acid Nanotechnology Development Corporation, Ltd
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
NA
Novel pRNA Nanoparticle Delivery as Directed Therapy for Colorectal Cancer Metastasis
Colorectal cancer is the second leading cause of cancer death in the U.S. When localized to the mucosa and submucosa of the bowel wall (Stage I), the five-year survival approaches 100% after resection; however, systemic metastasis (Stage IV), usually to the liver, is associated with a five-year survival that is less than 12%. Therefore, mor selective, highly innovative, and better targeted therapies are required if we are to achieve an improved patient survival.
Filed on October 30, 2015.
Tell us what you know about Peixuan Guo's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Peixuan Guo filed other conflict of interest disclosures with the NIH:
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Peixuan Guo | Ohio State University | Conflict of Interest | ExonanoRNA, LLC | $250,000 - $299,999 |
| Peixuan Guo | University of Louisville | Conflict of Interest | Guangzhou Biomotor and RNA Nanotech Development Co. Ltd. | $40,000 - $59,999 |
| Peixuan Guo | Ohio State University | Conflict of Interest | P & Z Biological Technology, LLC | $20,000 - $39,999 |
| Peixuan Guo | University of Louisville | Conflict of Interest | Nanobio Delivery Pharmaceutical | $10,000 - $19,999 |
| Peixuan Guo | Ohio State University | Conflict of Interest | P & Z Biological Technology, LLC | $0 - $4,999 |
| Peixuan Guo | University of Louisville | Conflict of Interest | Guangzhou Biomotor and RNA Nanotech Development Co. Ltd. | Value cannot be readily determined |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.